Best Grants for Cancer Nonprofits in Guam

Undergraduate-focused higher education institutions conducting biomedical or cancer research in Guam can apply for National Institutes of Health Academic Research Enhancement Awards, with awards up to US $375,000 for small-scale projects. Eligible colleges and universities must grant baccalaureate science degrees and have limited prior NIH funding, and may involve cancer-focused faculty and undergraduate students.

The Canine Cancer Immunotherapy Network (K9CIN) aims to advance canine cancer treatments through innovative clinical trials, paralleling the development of human therapies. This initiative is vital as pet dogs naturally develop cancer, mirroring human responses to treatments. By leveraging NIH support, K9CIN will facilitate research to enhance immunotherapeutic strategies for both dogs and humans, fostering a collaborative environment for veterinary and human medical advancements. Ultimately, this funding opportunity promotes ethical research that benefits both species.

This funding opportunity aims to bolster the cancer surveillance workforce through educational initiatives. By enhancing collaborations with cancer partners and developing tools for improved data quality, this program will expand the capacity of registrars. Efforts will focus on recruitment and retention, ultimately ensuring compliance with Public Law 102-515. Strengthening the cancer registrar workforce will lead to timely and accurate cancer data submission, supporting public health objectives.

NIH provides Guam cancer research institutions with US $1,200,000 - US $1,500,000 Cancer Center Support Grants to strengthen NCI-designated Cancer Centers. Funding supports leadership salaries, shared research resources, administration, planning and evaluation, and developmental funds for new recruitments and feasibility studies, helping advance prevention, diagnosis, treatment, and population-based cancer research.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers aiming to transition to independent faculty positions. It encourages candidates with doctoral degrees in research or clinical fields to apply, particularly those in cancer control and prevention. This funding opportunity facilitates a quick shift from mentored research to independent careers, providing essential support for awardees to establish competitive research programs without leading their own clinical trials.

The National Cancer Institute invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity supports both analytical and clinical validation of assays, emphasizing the importance of human samples. The program encourages multi-disciplinary collaboration and aims to enhance the performance and reproducibility of cancer assays across clinical laboratories. Applications are due by 5:00 PM local time during the designated deadlines each year.

The Exploratory Grant Award aims to enhance workforce diversity in basic cancer research by supporting junior and Early Stage Investigators from underrepresented groups in the biomedical and social sciences. This initiative provides essential funding to bridge the gap for researchers completing their training, ensuring they have the resources needed to develop larger grant applications. Applications are due by 5:00 PM local time of the applicant organization, emphasizing the importance of timely submissions.

Cancer research institutions and translational research centers working on human cancer can seek funding to advance prevention, early detection, diagnosis, and treatment in Guam and other U.S. territories. The National Cancer Institute’s SPORE P50 program offers US $25,000,000 for state-of-the-art, organ-specific or mechanism-based translational cancer research with clear human endpoints.

The Cancer Research Education Grants Program (R25) aims to enhance research education in areas crucial to the NIH mission. This program supports innovative courses that develop skills in cancer research, covering topics such as prevention, diagnosis, and treatment. Grant applications are encouraged to be creative and state-of-the-art, addressing the needs of patients and their families. Key deadlines for applications span from January 2024 to September 2026, ensuring ongoing support for educational initiatives.

The Cancer Health Equity Research Centers (CHERCs) initiative by the American Cancer Society aims to address health disparities by supporting research focused on social determinants affecting cancer care. This program encourages innovative projects that engage communities, enhance access, and improve outcomes across diverse populations. By fostering collaborations and promoting multidisciplinary approaches, CHERCs strive to create equitable cancer prevention and treatment solutions, ensuring that all individuals have fair opportunities for cancer care and survivorship.

The Institutional Research Grants (IRG) program by the American Cancer Society provides essential seed funding for newly independent investigators to launch cancer research projects. Aimed at junior faculty, these grants offer $120,000 annually for three years, supporting the development of preliminary results necessary for competing for larger national grants. Eligible applicants must be at US academic institutions and hold the rank of Associate or Full Professor, with a proven track record in research and mentorship.

The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) co-fund the Clinician Scientist Development Grant (CSDG), aimed at advancing the research careers of clinician scientists in radiation oncology. Eligible applicants are full-time faculty members at U.S. institutions with a doctoral degree and an active clinical license. The grant supports research for 3 to 5 years, providing $135,000 annually for direct costs, plus allowable indirect costs, while encouraging diversity in applications.

The Clinician Scientist Development Grant (CSDG) by the American Cancer Society supports full-time faculty aiming to become independent clinician scientists while maintaining clinical practice. Eligible applicants must hold a doctoral degree, an active clinical license, and have clinical care experience. The grant provides funding of $135,000 annually for 3 to 5 years, including allowable indirect costs, to advance cancer research in key priority areas.

The American Cancer Society's Mentored Research Grants for Postdoctoral Fellowships (PF) aim to support emerging researchers in their training programs, fostering their transition to independent cancer research careers. Eligible candidates include US citizens or non-citizens with valid visas who have completed their doctoral degrees within the last four years. The fellowship offers funding for up to three years, with stipends of $66,000 to $70,000 annually, alongside allowances for health insurance and professional development.

The Mission Boost Grants (MBG) by the American Cancer Society aim to enhance cancer research by funding projects that translate into human testing. These grants support investigators at all levels, offering resources for innovative clinical projects. The program consists of two funding stages: Stage I focuses on developing clear milestones for new treatments, while Stage II supports patient testing, ultimately contributing to advancements in cancer care and treatment.

The Discovery Boost Grants (DBG) offered by the American Cancer Society support innovative and high-risk exploratory cancer research. These grants, available for up to two years with a funding limit of $125,000 annually plus indirect costs, aim to generate preliminary data that can lead to further funding opportunities. Eligible applicants include independent investigators with a doctorate and a full-time faculty position, fostering advancements in cancer research across multiple priority areas.

Postdoctoral cancer researchers from nationally underrepresented backgrounds seeking to launch independent biomedical careers in Guam and other U.S. locations can apply for this career development award supporting clinical trial–required projects. Focused on cancer research and professional training, the National Institutes of Health provides three years of salary and research support as scientists transition into tenure-track roles.

Postdoctoral fellows and similar early-career cancer researchers in Guam and other eligible U.S. territories can seek up to US $150,000 to transition into independent research careers. With a mission to advance biomedical research, National Institutes of Health provides career development support that may benefit cancer-focused institutions and programs in Guam.

Clinical scientists pursuing mentored cancer research careers in Guam and other eligible U.S. jurisdictions can access career development funding through the National Institutes of Health. NIH provides support and protected time for underrepresented investigators to undertake intensive, supervised biomedical, behavioral, or translational cancer research, including cancer health disparities, to build toward future independent research project grants.

The NCI Worta McCaskill-Stevens Career Development Award supports new clinicians committed to research in community oncology and cancer prevention. This funding aims to facilitate their transition to independent research careers and advanced funding mechanisms. Scholars can lead independent community-based clinical trials, conduct ancillary studies, or gain valuable research experience, specifically targeting underserved communities. Applications are due by 5:00 PM local time of the applicant's organization.

Clinician-scientists pursuing mentored cancer research careers can apply for career development funding from the National Institutes of Health, including applicants in Guam. Focused on cancer and related biomedical, behavioral, and translational research, this K08 program supports intensive, supervised training for individuals from nationally underrepresented backgrounds, helping them build skills to compete for future independent research project grants.

Cancer and health disparities researchers in Guam and other eligible U.S. locations can seek funding for multi-level or multi-domain interventions to reduce disparities in liver diseases and liver cancer. US Dept. of Health & Human Services: National Institutes of Health supports projects focused on improving outcomes among populations experiencing health disparities.

With a mission to advance cancer research, NIH provides Guam cancer and oncology researchers with funding up to US $1,900,000 for pre-clinical nanotechnology-based diagnostics and therapeutics. Academic or research institutions developing nanoparticle or nano-device cancer interventions that can progress toward NCI translational programs may be strong candidates.

Postdoctoral cancer researchers planning clinical trials in Guam can access funding through the National Institutes of Health’s NCI Pathway to Independence Award (K99/R00). Grants from NIH help oncology and medical training professionals transition from mentored postdoctoral roles to independent, tenure-track or equivalent research positions while building competitive cancer research programs.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The National Human Genome Research Institute (NHGRI) is launching a Notice of Funding Opportunity (NOFO) aimed at enhancing genomic research through the development and distribution of high-value resources. This initiative encourages collaborative efforts in genomic resource development and the integration of data science in clinical applications. While applications are not currently being accepted, prospective applicants are urged to prepare meaningful collaborations and projects ahead of the formal solicitation.